{"title":"TGR5 dysfunction underlies chronic social defeat stress via cAMP/PKA signaling pathway in the hippocampus.","authors":"Xiangyu Chen, Qinji Zhou, Yong He, Yue Wang, Yanyi Jiang, Yi Ren, Yikun Ren, Junchao Cai, Heming Yu, Chong Chen, Ke Cheng, Peng Xie","doi":"10.1038/s41398-025-03599-7","DOIUrl":null,"url":null,"abstract":"<p><p>Major depressive disorder (MDD) is a debilitating mental health disorder that has a wide impact on many patients and has imposed a heavy burden on society in recent years. However, the specific pathogenesis of depression remains to be elucidated. Numerous studies have shown that metabolic disorders and molecules play important roles in MDD. Here, we demonstrate a preliminary mechanism through which TGR5 functions in the hippocampus during bile acid synthesis dysfunction in mice subjected to chronic social defeat stress (CSDS). According to the enzyme-linked immunosorbent assay (ELISA), susceptible mice subjected to CSDS presented reduced expression of key bile acid enzymes in the serum and total bile acids (TBAs) in the hippocampus. The expression of the bile acid-related receptor TGR5 in the hippocampus was lower in CSDS-exposed susceptible mice than in control mice. By analyzing the potential downstream signaling pathways of TGR5, we found that specific TGR5/cAMP/PKA regulation effectively increased the plasticity of Schaffer collateral (SC)-CA1 synapses in the hippocampus and further alleviated anxiety- and depression-like behavior in susceptible mice. These findings suggest that CSDS susceptibility is accompanied by dysfunction of TGR5 in the hippocampus and the downstream cAMP/PKA signaling pathway. Activating cAMP/PKA signaling can ameliorate behavioral deficits in susceptible mice. This study may support the development of potential effective pharmacotherapies for the treatment of MDD.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"15 1","pages":"366"},"PeriodicalIF":6.2000,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12501386/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-025-03599-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Major depressive disorder (MDD) is a debilitating mental health disorder that has a wide impact on many patients and has imposed a heavy burden on society in recent years. However, the specific pathogenesis of depression remains to be elucidated. Numerous studies have shown that metabolic disorders and molecules play important roles in MDD. Here, we demonstrate a preliminary mechanism through which TGR5 functions in the hippocampus during bile acid synthesis dysfunction in mice subjected to chronic social defeat stress (CSDS). According to the enzyme-linked immunosorbent assay (ELISA), susceptible mice subjected to CSDS presented reduced expression of key bile acid enzymes in the serum and total bile acids (TBAs) in the hippocampus. The expression of the bile acid-related receptor TGR5 in the hippocampus was lower in CSDS-exposed susceptible mice than in control mice. By analyzing the potential downstream signaling pathways of TGR5, we found that specific TGR5/cAMP/PKA regulation effectively increased the plasticity of Schaffer collateral (SC)-CA1 synapses in the hippocampus and further alleviated anxiety- and depression-like behavior in susceptible mice. These findings suggest that CSDS susceptibility is accompanied by dysfunction of TGR5 in the hippocampus and the downstream cAMP/PKA signaling pathway. Activating cAMP/PKA signaling can ameliorate behavioral deficits in susceptible mice. This study may support the development of potential effective pharmacotherapies for the treatment of MDD.
期刊介绍:
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.